Versatile Liquid Handling System Reduces Overall Cycle Times at GSK

11 January 2018

In this video, Melanie Leveridge, Head of Screening, Profiling and Mechanistic Biology at GlaxoSmithKline (GSK), Stevenage, UK, discusses her team’s goal of reducing overall cycle times in early drug discovery. Leveridge explains how her team closely collaborated with TTP Labtech in the design and development of the dragonfly® discovery liquid handling system that has accelerated assay development time.

DISCLAIMER: GSK supports the advancement of research and development but does not commercially endorse any technology.